Title |
The REMEDEE Trial A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent
|
---|---|
Published in |
JACC: Cardiovascular Interventions, March 2013
|
DOI | 10.1016/j.jcin.2012.10.018 |
Pubmed ID | |
Authors |
Michael Haude, Stephen W.L. Lee, Stephen G. Worthley, Sigmund Silber, Stefan Verheye, Sandra Erbs, Mohd Ali Rosli, Roberto Botelho, Ian Meredith, Kui Hian Sim, Pieter R. Stella, Huay-Cheem Tan, Robert Whitbourn, Sukumaran Thambar, Alexandre Abizaid, Tian Hai Koh, Peter Den Heijer, Helen Parise, Ecaterina Cristea, Akiko Maehara, Roxana Mehran |
Abstract |
This study sought to compare the efficacy and safety results after coronary implantation of a combined sirolimus-eluting CD34 antibody coated Combo stent (OrbusNeich Medical, Ft. Lauderdale, Florida) with the paclitaxel-eluting Taxus Liberté stent (PES) (Boston Scientific, Natick, Massachusetts). This report summarizes the first-in-man randomized, controlled multicenter REMEDEE trial (Randomized study to Evaluate the safety and effectiveness of an abluMinal sirolimus coatED bio-Engineered StEnt) angiographic, intravascular ultrasound, and clinical results up to 12 months. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Czechia | 1 | 1% |
Unknown | 97 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 18 | 18% |
Student > Bachelor | 14 | 14% |
Researcher | 13 | 13% |
Student > Postgraduate | 10 | 10% |
Student > Doctoral Student | 9 | 9% |
Other | 14 | 14% |
Unknown | 20 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 42 | 43% |
Biochemistry, Genetics and Molecular Biology | 5 | 5% |
Agricultural and Biological Sciences | 4 | 4% |
Computer Science | 3 | 3% |
Engineering | 3 | 3% |
Other | 12 | 12% |
Unknown | 29 | 30% |